The veterinary excipients are used in formulating the medications used in the treating animal diseases. The veterinary excipients is a substance used while formulating active ingredient of medication, included for the purpose of bulking up solid formulations, to confer a therapeutic enhancement on the active ingredient, reducing viscosity and for enhancing solubility. The excipients can also be beneficial during the manufacturing process to help with concerns relating to the active substance, such as by facilitating powder flowability or non-stick properties, in addition to aiding in vitro stability, such as by preventing denaturation or aggregation over the expected shelf life. The dosage form, mode of administration, active ingredient, and other variables all play a role in choosing the best excipients. For excipients used in parenteral pharmaceuticals, a thorough classification system based on correlations between structure, property, and application has been developed.

There are various functions of the excipients in the veterinary formulations, some of them are mentioned here as follows: fillers, disintegrants, binders, glidants, bulking agents, lubricants, buffering agents, tonicity Adjusting Agents, preservatives, antimicrobial agents, and antioxidants among others. For example: the antimicrobial agents are used in the parental formulation of the veterinary medication. The disintegrants. The tablet coating protect tablet ingredients from deterioration by moisture in the air and make large or unpleasant-tasting tablets easier to swallow. The binders are used in the veterinary formulation to hold the ingredients in a tablet together, the dry binders are added to the powder blend, either after a wet granulation step, or as part of a direct powder compression (DC) formula and the solution binders are dissolved in a solvent (for example water or alcohol can be used in wet granulation processes).

Market Dynamics

Increasing adoption of the inorganic strategies like acquisition and agreement to develop the new excipients and products and distribution of excipients to manufacturer is expected to drive the market over the forecast period. For instance, on October 4, 2022, Roquette, a plant-based pharmaceutical excipient provider, announced the acquisition of Crest Cellulose, an excipient manufacturer, to increase Roquette’s presence in Asia Pacific. Furthermore, in February, 2022, Azelis, a global innovation service provider in the specialty chemicals and food ingredients industry, announced an agreement with Roquette for the distribution of its pharmaceutical cellulose product range in India. This agreement will expand the company presence in multiple regions and industries.

Key features of the study:

• This report provides an in-depth analysis of the global veterinary excipients market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary excipients market   based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BASF SE, Croda Health Care, JRS Pharma, Lipoid GmbH, Azelis, U.K. Vet Chem, Gattefoss, Synergy API, Anzchem, Vantage.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary excipients market  report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary excipients market

Detailed Segmentation:

• Global Veterinary Excipients Market, By Functionality:
  • Fillers
  • Binders
  • Disintegrants 
  • Glidants
  • Lubricants
  • Bulking Agents
  • Buffering Agents
  • Tonicity Adjusting Agents
  • Preservatives
  • Antimicrobial Agents
  • Antioxidants
  • Others
• Global Veterinary Excipients Market, By Formulation:
  • Oral Formulation
  • Topical Formulations
  • Parenteral Formulations
  • Other Formulations
• Global Veterinary Excipients Market, By End User:
  • Pharmaceutical Companies
  • Contract Manufacturing Organization (CMO)
• Global Veterinary Excipients Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • BASF SE
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Croda Health Care
  • JRS Pharma
  • Lipoid GmbH
  • Azelis
  • U.K. Vet Chem
  • Gattefoss
  • Synergy API
  • Anzchem
  • Vantage

“*” marked represents similar segmentation in other categories in the respective section.